Loading
KP
Kite Pharma, Inc. Stock: price and insider trades · United States
Kite Pharma, Inc.: what insiders have been doing
Kite Pharma, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). No insider at Kite Pharma, Inc. has published a filing in the past twelve months. The most recent one dates from 16 February 2016.
Other companies in the same market with recent insider buying flagged by our signals: Relmada Therapeutics, Inc. and Uber Technologies, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
46
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
36 ops. · all time
Last declaration on 16 February 2016
Declarations46 total
18,750 sharesCommon StockSEC:0001209191-16-098979:1
18,750 sharesCommon StockSEC:0001209191-16-098979:0
1,900 sharesCommon StockSEC:0001209191-16-095879:0
1,900 sharesCommon StockSEC:0001209191-16-095879:1
9,000 sharesCommon StockSEC:0001209191-16-095525:0
2,499 sharesCommon StockSEC:0001209191-16-095525:1
4,938 sharesCommon StockSEC:0001209191-16-095525:2
1,410 sharesCommon StockSEC:0001209191-16-095525:3
153 sharesCommon StockSEC:0001209191-16-095525:4
8,100 sharesCommon StockSEC:0001209191-16-094259:0
2,500 sharesCommon StockSEC:0001209191-16-094259:1
2,700 sharesCommon StockSEC:0001209191-16-094259:2
2,800 sharesCommon StockSEC:0001209191-16-094259:3
100 sharesCommon StockSEC:0001209191-16-094259:4
5,500 sharesCommon StockSEC:0001209191-16-092245:0
645 sharesCommon StockSEC:0001209191-16-092245:1
264 sharesCommon StockSEC:0001209191-16-092245:2
700 sharesCommon StockSEC:0001209191-16-092245:3
3,527 sharesCommon StockSEC:0001209191-16-092245:4
1,054 sharesCommon StockSEC:0001209191-16-092245:5
645 sharesCommon StockSEC:0001209191-16-092246:2
3,166 sharesCommon StockSEC:0001209191-16-092246:3
1,918 sharesCommon StockSEC:0001209191-16-092246:4
800 sharesCommon StockSEC:0001209191-16-092246:5
2,767 sharesCommon StockSEC:0001209191-16-092246:6
25 of 46 declarations
About Kite Pharma, Inc.
Kite Pharma, Inc. is a biopharmaceutical company focused on developing cell therapies for cancer treatment. It is listed on the NASDAQ under the ticker symbol KITE.
